Literature DB >> 21836088

Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the northern Manhattan study.

Justin Marcus1, Hannah Gardener, Tatjana Rundek, Mitchell S V Elkind, Ralph L Sacco, Charles Decarli, Clinton B Wright.   

Abstract

BACKGROUND AND
PURPOSE: Elevated blood pressure (BP) is a risk factor for stroke and dementia, but the effect of BP, and change in BP over time, on white matter hyperintensity volume (WMHV) is not fully understood. Few studies have included Hispanics, who are at greater risk of stroke and dementia than non-Hispanic whites. We examined BP in relation to WMHV in a stroke-free cohort.
METHODS: The Northern Manhattan Study includes 1290 stroke-free participants who had brain MRI. We examined baseline systolic and diastolic (DBP) BP, and changes in BP from baseline to MRI, and WMHV.
RESULTS: There were 1281 participants with brain MRI and 2 BP measurements (mean age, 64 years; SD=8; range, 40 to 94 years). Baseline DBP was associated with greater WMHV (P<0.0001) independent of sociodemographic and vascular risk factors. Each 10 mm Hg above the mean baseline DBP (83±11 mm Hg) was associated with a 1.17% greater WMHV. Over 7 years average follow-up, participants with an increase >5 mm Hg DBP from baseline to MRI had 1.21% greater WMHV relative to those whose BP did not increase (P=0.02). The association between baseline DBP and WMHV was strongest for blacks compared with Hispanics and whites (interaction P=0.04).
CONCLUSIONS: Baseline DBP and longitudinal increases in DBP were independently associated with a greater WMHV, and the association between DBP and WMHV was greatest among blacks.

Entities:  

Mesh:

Year:  2011        PMID: 21836088      PMCID: PMC3189513          DOI: 10.1161/STROKEAHA.111.617571

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Blood pressure components and changes in relation to white matter lesions: a 32-year prospective population study.

Authors:  Xinxin Guo; Leonardo Pantoni; Michela Simoni; Calle Bengtsson; Cecilia Björkelund; Lauren Lissner; Deborah Gustafson; Ingmar Skoog
Journal:  Hypertension       Date:  2009-06-01       Impact factor: 10.190

2.  Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan.

Authors:  Adam M Brickman; Nicole Schupf; Jennifer J Manly; José A Luchsinger; Howard Andrews; Ming X Tang; Christiane Reitz; Scott A Small; Richard Mayeux; Charles DeCarli; Truman R Brown
Journal:  Arch Neurol       Date:  2008-08

Review 3.  Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease.

Authors:  D M Moody; W R Brown; V R Challa; H S Ghazi-Birry; D M Reboussin
Journal:  Ann N Y Acad Sci       Date:  1997-09-26       Impact factor: 5.691

4.  Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

Authors:  R L Sacco; B Boden-Albala; R Gan; X Chen; D E Kargman; S Shea; M C Paik; W A Hauser
Journal:  Am J Epidemiol       Date:  1998-02-01       Impact factor: 4.897

5.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

6.  High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study.

Authors:  R L Sacco; R T Benson; D E Kargman; B Boden-Albala; C Tuck; I F Lin; J F Cheng; M C Paik; S Shea; L Berglund
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

7.  Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.

Authors:  Clinton B Wright; Myunghee C Paik; Truman R Brown; Sally P Stabler; Robert H Allen; Ralph L Sacco; Charles DeCarli
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

8.  Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Rebecca F Gottesman; Josef Coresh; Diane J Catellier; A Richey Sharrett; Kathryn M Rose; Laura H Coker; Dean K Shibata; David S Knopman; Clifford R Jack; Thomas H Mosley
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

9.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

Review 10.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26
  10 in total
  38 in total

Review 1.  Brain health and shared risk factors for dementia and stroke.

Authors:  Hannah Gardener; Clinton B Wright; Tatjana Rundek; Ralph L Sacco
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

2.  Blood Pressure and Cognitive Decline Over 8 Years in Middle-Aged and Older Black and White Americans.

Authors:  Deborah A Levine; Andrzej T Galecki; Kenneth M Langa; Frederick W Unverzagt; Mohammed U Kabeto; Bruno Giordani; Mary Cushman; Leslie A McClure; Monika M Safford; Virginia G Wadley
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 3.  Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Masafumi Ihara; Albertino Damasceno; Adesola Ogunniyi; Catherine Dotchin; Stella-Maria Paddick; Julius Ogeng'o; Richard Walker; Raj N Kalaria
Journal:  Brain Res Bull       Date:  2018-05-25       Impact factor: 4.077

4.  Blood Pressure and Heart Rate Measures Associated With Increased Risk of Covert Brain Infarction and Worsening Leukoaraiosis in Older Adults.

Authors:  Lester Y Leung; Traci M Bartz; Kenneth Rice; James Floyd; Bruce Psaty; Jose Gutierrez; W T Longstreth; Kenneth J Mukamal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-29       Impact factor: 8.311

Review 5.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

Review 6.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Authors:  Clinton B Wright; Nirav H Shah; Armando J Mendez; Janet T DeRosa; Mitsuhiro Yoshita; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Tatjana Rundek; Shonni Silverberg; Chuanhui Dong; Myles Wolf
Journal:  Stroke       Date:  2016-03-08       Impact factor: 7.914

8.  Hypertension and Migraine in the Northern Manhattan Study.

Authors:  Hannah Gardener; Teshamae Monteith; Tatjana Rundek; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

9.  MRI Markers Predict Cognitive Decline Assessed by Telephone Interview: The Northern Manhattan Study.

Authors:  Clinton B Wright; Chuanhui Dong; Michelle R Caunca; Janet DeRosa; Ying Kuen Cheng; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

10.  Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study.

Authors:  Jose Gutierrez; Mitchell S V Elkind; Ken Cheung; Tatjana Rundek; Ralph L Sacco; Clinton B Wright
Journal:  J Hypertens       Date:  2015-10       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.